↓ Skip to main content

American Association for Cancer Research

Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

Overview of attention for article published in Cancer Discovery, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
9 news outlets
twitter
81 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
55 Mendeley
Title
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
Published in
Cancer Discovery, February 2021
DOI 10.1158/2159-8290.cd-20-1408
Pubmed ID
Authors

Daniel V.T. Catenacci, Stephanie Moya, Samantha Lomnicki, Leah M. Chase, Bryan F. Peterson, Natalie Reizine, Lindsay Alpert, Namrata Setia, Shu-Yuan Xiao, John Hart, Uzma D. Siddiqui, D. Kyle Hogarth, Oliver S. Eng, Kiran Turaga, Kevin Roggin, Mitchell C. Posner, Paul Chang, Sunil Narula, Murtuza Rampurwala, Yuan Ji, Theodore Karrison, Chih-Yi Liao, Blase N. Polite, Hedy L. Kindler

X Demographics

X Demographics

The data shown below were collected from the profiles of 81 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 16%
Other 8 15%
Student > Ph. D. Student 7 13%
Student > Master 5 9%
Student > Bachelor 4 7%
Other 9 16%
Unknown 13 24%
Readers by discipline Count As %
Medicine and Dentistry 24 44%
Biochemistry, Genetics and Molecular Biology 4 7%
Agricultural and Biological Sciences 3 5%
Chemical Engineering 2 4%
Mathematics 1 2%
Other 5 9%
Unknown 16 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 103. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2023.
All research outputs
#404,735
of 25,347,437 outputs
Outputs from Cancer Discovery
#200
of 4,045 outputs
Outputs of similar age
#11,843
of 522,214 outputs
Outputs of similar age from Cancer Discovery
#18
of 162 outputs
Altmetric has tracked 25,347,437 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,045 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 522,214 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.